1-19 of 19
Keywords: Dopamine
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Eur Neurol (2012) 67 (1): 4–11.
Published Online: 30 November 2011
...Jaime Kulisevsky; Michael Poyurovsky Parkinson’s disease and drug-induced movement disorders (DIMDs) have commonalities in etiology based on impaired dopamine-based neurotransmission. Adenosine A 2A -receptor antagonism may provide a new mechanism through which these disorders can be managed...
Journal Articles
Eur Neurol (2011) 66 (1): 18–29.
Published Online: 28 June 2011
... unclear, although roles for dopamine dysfunction and brain iron deficiency have been proposed. The hypothalamic A11 dopaminergic circuit is used to explain the dopamine dysfunction in RLS and the potential therapeutic actions of dopamine D 2 agonists. Modulation of central and peripher- al neuronal...
Journal Articles
Eur Neurol (1993) 33 (Suppl. 1): 44–51.
Published Online: 20 February 2008
... with dopa or dopamine. Either a-tocopherol or desferrioxamine completely abolished the dopa-Fe 3+ complex-induced phospholipid peroxidation, while SOD, catalase or sodium benzoate did not. A ferroxidase, ceruloplasmin, significantly inhibited the lipid peroxidation induced by the dopa-Fe 3+ complex...
Journal Articles
Eur Neurol (1990) 30 (4): 194–199.
Published Online: 14 February 2008
... of plasma dopamine compared to plasma L-dopa after dosing. The L-dopa-induced reduction in BP was thought to be due to a central nervous mechanism. 11 07 1989 14 09 1989 14 2 2008 © 1990 S. Karger AG, Basel 1990 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved...
Journal Articles
Journal Articles
Eur Neurol (1990) 30 (Suppl. 1): 31–40.
Published Online: 12 February 2008
... dyskinesia has been considered to be due to abnormalities in the serotonin neuronal system. However, the present study also demonstrated marked alterations in the dopamine (DA) and acetylcholine (ACh) neuronal systems. These were activation of DA neurons in the nucleus accumbens and thalamus + midbrain...
Journal Articles
Eur Neurol (1990) 30 (Suppl. 1): 15–20.
Published Online: 12 February 2008
...Michael J. Kuhar; Patricia M. Sanchez-Roa; Dean F. Wong; Robert F. Dannals; Dimitri E. Grigoriadis; Robert Lew; Michele Milberger In recent years, there has been substantial progress in studying the dopamine transporter, a unique component of the functioning dopaminergic nerve terminal...
Journal Articles
Eur Neurol (1989) 29 (3): 141–144.
Published Online: 06 February 2008
... interest in PD. It has been suggested that the glabellar response is related to inhibition via dopamine pathways. We examined changes in several primitive reflexes as a function of the plasma dopamine level and the severity of PD. The probability of observing these reflexes did not vary with dopamine...
Journal Articles
Eur Neurol (1987) 26 (Suppl. 1): 2–10.
Published Online: 06 February 2008
... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Parkinson’s disease Substantia nigra Dopamine MPTP Locus ceruleus Lewy bodies Etiology ...
Journal Articles
Eur Neurol (1988) 28 (2): 84–86.
Published Online: 05 February 2008
...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Indeloxazine Homovanillic acid 5-Hydroxyindoleacetic acid Methoxyhydroxyphenylen glycol Dopamine Cerebrospinal fluid...
Journal Articles
Eur Neurol (1987) 27 (1): 35–38.
Published Online: 05 February 2008
... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. L-Dopa Dopamine Periodic movements in sleep Narcolepsy Hypersomnolence Sleep ...
Journal Articles
Eur Neurol (1984) 23 (1): 26–33.
Published Online: 31 January 2008
... hyperactivity is presumably enhanced by relatively increased neostriatal catecholestrogens. The hypothesis of polycythaemic excess of dopamine-laden platelets releasing excess of dopamine in the neostriatum needs to be confirmed by laboratory evidence of platelet counts. 1 07 1983 11 08 1983 31 1...
Journal Articles
Journal Articles
Eur Neurol (1974) 12 (5-6): 340–350.
Published Online: 25 January 2008
... the HVA levels and improvement after L-dopa therapy in patients with relatively high levels of the dopamine catabolite. Patients with normal HVA levels in the cerebrospinal fluid did not respond to L-dopa. Also patients with extremely low HVA levels did not respond to L-dopa in a predictable way...
Journal Articles
Eur Neurol (1975) 13 (6): 513–518.
Published Online: 25 January 2008
... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Glabellar reflex Parkinson’s disease Reserpine Dopamine ...
Journal Articles
Eur Neurol (1970) 4 (3): 148–163.
Published Online: 22 January 2008
...H.L. Klawans, Jr. The major site of pathology in Huntington''s chorea is the striatum. The neurons of the striatum degenerate but the striatal content of dopamine remains normal. It is proposed that abnormally heightened responsiveness on the part of striatal receptors to dopamine underlies...
Journal Articles
Eur Neurol (1997) 38 (Suppl. 2): 33–36.
Published Online: 11 January 2008
..., instructions or products referred to in the content or advertisements. Parkinson's disease Dementia Dopamine Cortico-striato-pallido-thalamic loop ...
Journal Articles
Eur Neurol (1997) 38 (Suppl. 2): 26–32.
Published Online: 11 January 2008
... to in the content or advertisements. Positron emission tomography Parkinson's disease Dopamine Mesencephalic tissue, fetal Transplants Motor disturbance ...
Journal Articles
Eur Neurol (1997) 38 (3): 175–183.
Published Online: 09 January 2008
...Alberto Albanese This paper provides a critical review on the most recent developments in the treatment of Parkinson''s disease. New symptomatic therapies include the use of catechol-O-methyltransferase (COMT) inhibitors, new dopamine agonists and of surgical treatments (such as pallidotomy or deep...